Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://lulujtir920158.blogsuperapp.com/39556278/trelaglutide-exploring-a-new-treatment-for-chronic-diseases